Butyl ((4'-((2-((3r,5r,7r)-adamantan-1-yl)-1H-benzo[d]imidazol-1-yl)methyl)-5-propyl-[1,1'-biphenyl]-2-yl)sulfonyl)carbamate

ID: ALA5189691

Chembl Id: CHEMBL5189691

PubChem CID: 168283187

Max Phase: Preclinical

Molecular Formula: C38H45N3O4S

Molecular Weight: 639.86

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCOC(=O)NS(=O)(=O)c1ccc(CCC)cc1-c1ccc(Cn2c(C34CC5CC(CC(C5)C3)C4)nc3ccccc32)cc1

Standard InChI:  InChI=1S/C38H45N3O4S/c1-3-5-17-45-37(42)40-46(43,44)35-16-13-26(8-4-2)21-32(35)31-14-11-27(12-15-31)25-41-34-10-7-6-9-33(34)39-36(41)38-22-28-18-29(23-38)20-30(19-28)24-38/h6-7,9-16,21,28-30H,3-5,8,17-20,22-25H2,1-2H3,(H,40,42)

Standard InChI Key:  XDEYNJDHNDMHTI-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5189691

    ---

Associated Targets(Human)

AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR2 Tchem Angiotensin II type 2 (AT-2) receptor (2549 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 639.86Molecular Weight (Monoisotopic): 639.3131AlogP: 8.39#Rotatable Bonds: 11
Polar Surface Area: 90.29Molecular Species: ACIDHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.93CX Basic pKa: 5.42CX LogP: 7.65CX LogD: 8.57
Aromatic Rings: 4Heavy Atoms: 46QED Weighted: 0.17Np Likeness Score: -0.57

References

1. Roy T, Petersen NN, Gopalan G, Gising J, Hallberg M, Larhed M..  (2022)  2-Alkyl substituted benzimidazoles as a new class of selective AT2 receptor ligands.,  66  [PMID:35576659] [10.1016/j.bmc.2022.116804]

Source